Analystreport

Ironwood Pharmaceuticals (NASDAQ: IRWD) is now covered by analysts at Berenberg Bank. They set a "buy" rating and a $25.00 price target on the stock.

Ironwood Pharmaceuticals, Inc. - Class A  (IRWD) 
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com